Tag Archives: ECYT

Top 10 Casino Stocks To Invest In 2019

The casino sector offers a lot of color beyond the characters one expects to find as their customers according to the movies. Local nuances in Macau, Las Vegas, online gambling, and new areas lead to industry-wide changes and company-level opportunities for investors.

Recent headlines have focused on headwinds in Macau – with revenue down for its third consecutive year but perhaps bottoming – potential tailwinds in Japan, and the possibility of liberalization of online gambling and sports betting laws in the US. That said, the general performance of the sector’s leading lights has not been great.

Top 10 Casino Stocks To Invest In 2019: Citi Trends, Inc.(CTRN)

Advisors’ Opinion:

  • [By Logan Wallace]

    Sidoti started coverage on shares of Citi Trends (NASDAQ:CTRN) in a research report released on Friday, MarketBeat Ratings reports. The firm issued a buy rating and a $28.00 target price on the stock.

  • [By Logan Wallace]

    Citi Trends (NASDAQ:CTRN) updated its third quarter earnings guidance on Thursday. The company provided EPS guidance of ($0.03) – $0.02 for the period, compared to the Thomson Reuters consensus EPS estimate of $0.05. The company issued revenue guidance of +2-3% to ~$180.4-182.2 million, compared to the consensus revenue estimate of $181.80 million.Citi Trends also updated its Q4 guidance to $0.60-0.65 EPS.

  • [By Stephan Byrd]

    Citi Trends (NASDAQ:CTRN) will issue its quarterly earnings data before the market opens on Wednesday, May 23rd. Analysts expect the company to announce earnings of $0.90 per share for the quarter. Citi Trends has set its FY19 guidance at $1.55-1.70 EPS.

  • [By Logan Wallace]

    Citi Trends (NASDAQ: CTRN) and Hanesbrands (NYSE:HBI) are both retail/wholesale companies, but which is the better stock? We will contrast the two businesses based on the strength of their earnings, valuation, dividends, risk, profitability, analyst recommendations and institutional ownership.

  • [By Stephan Byrd]

    Get a free copy of the Zacks research report on Citi Trends (CTRN)

    For more information about research offerings from Zacks Investment Research, visit Zacks.com

Top 10 Casino Stocks To Invest In 2019: Odyssey Marine Exploration Inc.(OMEX)

Advisors’ Opinion:

  • [By Joseph Griffin]

    Kenon (NYSE: KEN) and Odyssey Marine Exploration (NASDAQ:OMEX) are both small-cap utilities companies, but which is the superior business? We will contrast the two businesses based on the strength of their profitability, valuation, analyst recommendations, earnings, institutional ownership, risk and dividends.

  • [By Money Morning Staff Reports]

    After looking at this week’s penny stock gainers, we’ll give you that leg up with one of our top-rated penny stocks from our proprietary stock ranking system…

    Penny Stock Current Share Price (March 26) Last Week’s Gain
    Cartesian Inc. (OTCMKTS: CRTN) $0.39 170.69%
    Odyssey Marine Exploration Inc. (Nasdaq: OMEX) $8.76 135.90%
    iFresh Inc. (Nasdaq: IFMK) $8.25 64.64%
    China Auto Logistics Inc. (Nasdaq: CALI) $4.68 47.43%
    National American University Holdings Inc. (Nasdaq: NAUH) $1.20 39.29%
    Document Security Systems Inc. (NYSE: DSS) $1.58 33.91%
    Blonder Tongue Labs Inc. (NYSE: BDR) $0.77 33.90%
    CareDx Inc. (Nasdaq: CDNA) $7.49 29.88%
    Mediwound Ltd. (Nasdaq: MDWD) $5.10 26.51%
    New York & Co. Inc. (NYSE: NWY) $3.37 26.35%

    Don’t Miss This Shot at a $78,000 Windfall: This tiny firm is about to make the entire world wire-free. As its game-changing technology revolutionizes the global power structure, its stock could hand investors a massive return. Learn more…

  • [By Joseph Griffin]

    News stories about Odyssey Marine Exploration (NASDAQ:OMEX) have trended somewhat positive recently, according to Accern. The research firm identifies positive and negative news coverage by reviewing more than 20 million blog and news sources. Accern ranks coverage of publicly-traded companies on a scale of negative one to one, with scores closest to one being the most favorable. Odyssey Marine Exploration earned a media sentiment score of 0.01 on Accern’s scale. Accern also assigned media coverage about the business services provider an impact score of 46.3184749361846 out of 100, indicating that recent news coverage is somewhat unlikely to have an effect on the stock’s share price in the next several days.

  • [By Max Byerly]

    Odyssey Marine Exploration (NASDAQ: OMEX) and Teekay Offshore Partners (NYSE:TOO) are both small-cap transportation companies, but which is the better investment? We will compare the two businesses based on the strength of their dividends, risk, analyst recommendations, profitability, institutional ownership, valuation and earnings.

Top 10 Casino Stocks To Invest In 2019: U.S. Bancorp(USB)

Advisors’ Opinion:

  • [By Max Byerly]

    Get a free copy of the Zacks research report on U.S. Bancorp (USB)

    For more information about research offerings from Zacks Investment Research, visit Zacks.com

  • [By Ethan Ryder]

    Indiana Trust & Investment Management CO acquired a new stake in U.S. Bancorp (NYSE:USB) in the second quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission (SEC). The fund acquired 14,613 shares of the financial services provider’s stock, valued at approximately $731,000.

  • [By Shane Hupp]

    Investors bought shares of U.S. Bancorp (NYSE:USB) on weakness during trading on Friday. $366.36 million flowed into the stock on the tick-up and $39.37 million flowed out of the stock on the tick-down, for a money net flow of $326.99 million into the stock. Of all stocks tracked, U.S. Bancorp had the 21st highest net in-flow for the day. U.S. Bancorp traded down ($0.21) for the day and closed at $55.14

  • [By Logan Wallace]

    Traders sold shares of U.S. Bancorp (NYSE:USB) on strength during trading hours on Wednesday. $24.99 million flowed into the stock on the tick-up and $87.08 million flowed out of the stock on the tick-down, for a money net flow of $62.09 million out of the stock. Of all equities tracked, U.S. Bancorp had the 21st highest net out-flow for the day. U.S. Bancorp traded up $0.09 for the day and closed at $54.33

  • [By Garrett Baldwin]

    Morgan Stanley (NYSE: MS) leads a busy day of earnings reports. The company reported earnings per share (EPS) of $1.37 on top of $11.08 billion in revenue. Analysts projected EPS of $1.28 on top of $10.45 billion in revenue. Shares of MS stock popped 2.4% thanks to stronger profits (a 26% jump) from the company’s trading division. Recent market volatility has benefited the trading operations of Wall Street investment banks. Here’s how you can tap into volatility for big profits this week. Once again, markets are keeping a close eye on ongoing issues between the United States and its largest trading partners. According to reports, trade problems are expected to offset any gains projected from recent tax reform. The news comes as China is looking to get other U.S. trade partners to stand on their side and oppose American protectionism. Meanwhile, NAFTA officials are set to meet in Washington in order to accelerate the renegotiation of the three-nation trade agreement. This news comes the same morning that U.S. President Donald Trump took to Twitter to bash the Trans-Pacific Partnership. “While Japan and South Korea would like us to go back into TPP, I don’t like the deal for the United States,” he tweeted. Trump recently raised the possibility that the United States could join the 11-nation deal. Farming groups have been pushing Trump to rejoin the treaty due to the competitive disadvantage they will face against farmers in Canada, Mexico, and Australia, three member states of the deal.
    Three Stocks to Watch Today: MS, AXP, AXP
    International Business Machines Corp.(NYSE: IBM) shares plunged more than 5.4% in pre-market hours after the company reported weaker-than-expected forward guidance after the bell on Tuesday. The company reported EPS of $2.45, a figure that beat analysts’ expectations by $0.03. Its $19.1 billion in revenue also topped Wall Street expectations. However, the firm fell short on its annual profit outlook. People are lining up again to gi

  • [By Joseph Griffin]

    Get a free copy of the Zacks research report on U.S. Bancorp (USB)

    For more information about research offerings from Zacks Investment Research, visit Zacks.com

Top 10 Casino Stocks To Invest In 2019: Rice Midstream Partners LP(RMP)

Advisors’ Opinion:

  • [By Joseph Griffin]

    TC PIPELINES LP Common Stock (NYSE: TRP) and Rice Midstream Partners (NYSE:RMP) are both oils/energy companies, but which is the superior stock? We will compare the two companies based on the strength of their analyst recommendations, profitability, earnings, dividends, valuation, risk and institutional ownership.

  • [By Logan Wallace]

    Williams Companies (NYSE: WMB) and Rice Midstream Partners (NYSE:RMP) are both oils/energy companies, but which is the superior business? We will compare the two companies based on the strength of their dividends, risk, analyst recommendations, profitability, earnings, institutional ownership and valuation.

  • [By Stephan Byrd]

    These are some of the media headlines that may have effected Accern’s scoring:

    Get Rice Midstream Partners alerts:

    Investor Expectations to Drive Momentum within Balchem, Beacon Roofing Supply, Rice Midstream Partners LP, LTC Properties, Ubiquiti Networks, and 1st Source — Discovering Underlying Factors of Influence (finance.yahoo.com) Rice Midstream Partners (RMP) Rating Lowered to Strong Sell at ValuEngine (americanbankingnews.com) Zacks: Brokerages Expect Rice Midstream Partners (RMP) to Announce $0.40 EPS (americanbankingnews.com) Rice Midstream: 1Q Earnings Snapshot (finance.yahoo.com) Rice Midstream Partners (RMP) Announces $0.30 Dividend (americanbankingnews.com)

    RMP stock opened at $17.88 on Friday. The stock has a market capitalization of $1,871.10, a P/E ratio of 10.63, a P/E/G ratio of 0.74 and a beta of 1.17. Rice Midstream Partners has a 52 week low of $16.87 and a 52 week high of $26.00. The company has a debt-to-equity ratio of 0.13, a current ratio of 2.91 and a quick ratio of 2.91.

  • [By Stephan Byrd]

    Media headlines about Rice Midstream Partners (NYSE:RMP) have trended somewhat positive on Thursday, according to Accern. Accern ranks the sentiment of news coverage by reviewing more than 20 million blog and news sources. Accern ranks coverage of publicly-traded companies on a scale of negative one to one, with scores nearest to one being the most favorable. Rice Midstream Partners earned a news impact score of 0.07 on Accern’s scale. Accern also gave media stories about the oil and gas producer an impact score of 45.5093510879888 out of 100, meaning that recent news coverage is somewhat unlikely to have an impact on the company’s share price in the next few days.

Top 10 Casino Stocks To Invest In 2019: Panasonic Corporation (PCRFY)

Advisors’ Opinion:

  • [By SEEKINGALPHA.COM]

    JOLED is a company that was established in 2014 by by Japan Display, Sony (NYSE:SNE) and Panasonic (OTCPK:PCRFY). And they are not the only ones:

    During an OLED display Seminar in Korea, UniJet’s CEO Kim Seok-Soon said that new advances in Ink-Jet printing technologies could enable displays that are over 500 PPI – and so make printing a viable technology to produce small and medium-sized OLED panels.

  • [By ]

    The production issue for batteries may improve with added input from partner Panasonic (OTCPK:PCRFY). They currently produce battery cells for Tesla in Nevada, and in Japan. At their recent earnings call CEO Kazuhiro Tsuga said they were looking at manufacturing battery cells at a new plant in China in conjunction with Tesla. They also predicted their automation energy business profit would double this year. This can be seen as a vote of confidence in Tesla and a bullish sign for Tesla stock. However, according to reports in the Nikkei Asian Review, there is as yet no definite commitment for a joint venture in China. Panasonic is the world’s largest battery supplier for EV’s.

  • [By Ethan Ryder]

    Panasonic (OTCMKTS:PCRFY) was downgraded by equities researchers at ValuEngine from a “sell” rating to a “strong sell” rating in a research note issued to investors on Thursday.

  • [By ]

    CBAK is in a very competitive industry, as well as being small relative to its competitors. Among the Company’s competitors are giants like Panasonic (OTCPK:PCRFY) and Samsung (OTC:SSNLF), but overall it faces competition from Japan, Korea, and China. Although CBAK states that “we are able to leverage our low-cost advantage to compete favorably with our competitors”, it is hard to see that being the reality, especially when looking at the above gross margins. Still, the Company may enjoy lower labor costs, since it sources labor locally and apparently it has “higher consistency and safety in product quality, which enables us to compete favorably with local competitors”. But given the greater resources of at least some of its competitors and the constantly evolving dynamics of the industry, competition is surely a risk factor to consider.

  • [By ]

    However, Panasonic (OTCPK:PCRFY) announced this week that it was happy to consider further investment in the Nevada facility. A similar move in China is not unlikely. Tesla expects to triple its energy storage business this year but its problem has been getting supply to meet the demand. Panasonic’s announcement is probably connected to a very substantial energy storage contract win just announced by the company.

Top 10 Casino Stocks To Invest In 2019: SORL Auto Parts Inc.(SORL)

Advisors’ Opinion:

  • [By Lisa Levin]

    SORL Auto Parts, Inc. (NASDAQ: SORL) is expected to report quarterly earnings at $0.19 per share on revenue of $86.96 million.

    Aldeyra Therapeutics, Inc. (NASDAQ: ALDX) is projected to report quarterly loss at $0.39 per share.

  • [By Max Byerly]

    SORL Auto Parts (NASDAQ: SORL) and Modine Manufacturing (NYSE:MOD) are both small-cap auto/tires/trucks companies, but which is the superior investment? We will contrast the two companies based on the strength of their earnings, profitability, dividends, institutional ownership, valuation, analyst recommendations and risk.

  • [By Lisa Levin] Gainers
    Euro Tech Holdings Company Limited (NASDAQ: CLWT) shares rose 14.1 percent to $3.65 in the pre-market trading session after reporting 2017 year-end results.
    LightPath Technologies, Inc. (NASDAQ: LPTH) rose 13.3 percent to $2.43 in pre-market trading after reporting a third-quarter earnings beat.
    MYnd Analytics, Inc. (NASDAQ: MYND) rose 10.5 percent to $3.49 in pre-market trading. MYnd Analytics reported a Q2 net loss of $2.7 million on revenue of $459,900.
    SORL Auto Parts, Inc. (NASDAQ: SORL) shares rose 8.4 percent to $5.68 in pre-market trading after reporting upbeat Q1 results.
    Famous Dave's of America, Inc. (NASDAQ: DAVE) shares rose 7.7 percent to $8.40 in pre-market trading after the company reported upbeat earnings for its first quarter on Monday.
    Xenon Pharmaceuticals Inc. (NASDAQ: XENE) rose 7.5 percent to $6.45 in pre-market trading after the company presented XEN901 Phase 1 clinical update and XEN1101 TMS pharmacodynamic Phase 1 data.
    Mimecast Ltd (NASDAQ: MIME) rose 6.5 percent to $43.50 in pre-market trading following a first-quarter sales beat.
    Boxlight Corporation (NASDAQ: BOXL) rose 6 percent to $12.50 in pre-market trading after surging 77.44 percent on Monday.
    Intellia Therapeutics, Inc. (NASDAQ: NTLA) shares rose 6 percent to $26.05 in pre-market trading after climbing 3.58 percent on Monday.
    PPDAI Group Inc. (NASDAQ: PPDF) rose 4.7 percent to $7.20 in pre-market trading following Q1 results.
    Xunlei Limited (NASDAQ: XNET) rose 4.1 percent to $13.88 in pre-market trading after gaining 2.54 percent on Monday.
    Valeant Pharmaceuticals International, Inc. (NYSE: VRX) shares rose 4.5 percent to $21.73 in pre-market trading. Mizuho upgraded Valeant from Neutral to Buy.
    Bovie Medical Corporation (NYSE: BVX) rose 4.1 percent to $3.80 in pre-market trading after reporting a first-quarter sales beat.
    Myomo, Inc. (NYSE: MYO) rose 3.4 percent to $4.00 in pre-market trading after jumping 23.25 percent o
  • [By Lisa Levin] Gainers
    Euro Tech Holdings Company Limited (NASDAQ: CLWT) shares climbed 70.3 percent to $5.45 after reporting 2017 year-end results.
    MEDIGUS Ltd/S ADR (NASDAQ: MDGS) surged 39.8 percent to $1.58 in reaction to its Monday announcement of a distribution agreement. The medical device company said it reached an agreement to distribute its minimally invasive medical devices in Turkey, Azerbaijan and Georgia.
    Arcadia Biosciences, Inc. (NASDAQ: RKDA) gained 25.6 percent to $11.50. Arcadia Biosciences reported that Albert D. Bolles, Ph.D. has joined its board of directors.
    Aytu Bioscience Inc (NASDAQ: AYTU) shares jumped 21.8 percent to $0.4798 after the company late Monday reported lighter-than-expected Q1 loss.
    Hollysys Automation Technologies Ltd. (NASDAQ: HOLI) shares gained 21.1 percent to $26.77 following Q3 results.
    Pfenex Inc. (NYSE: PFNX) rose 16.8 percent to $7.1271 after the company announced the positive top-line PF708 study results in Osteoporosis patients that showed no imbalances in severity or incidence of adverse events.
    MEI Pharma, Inc. (NASDAQ: MEIP) rose 13.8 percent to $2.88.
    Red Violet, Inc. (NASDAQ: RDVT) jumped 13.1 percent to $6.41 after reporting Q1 results.
    SORL Auto Parts, Inc. (NASDAQ: SORL) shares gained 12 percent to $5.87 after reporting upbeat Q1 results.
    Bovie Medical Corporation (NYSE: BVX) gained 8.4 percent to $3.96 after reporting a first-quarter sales beat.
    Rosehill Resources Inc. (NASDAQ: ROSE) surged 8.4 percent to $7.90 after announcing Q1 results.
    LiqTech International, Inc. (NASDAQ: LIQT) rose 8.1 percent to $0.5171 following Q1 results.
    ProPhase Labs, Inc. (NASDAQ: PRPH) rose 7.7 percent to $5.6103 following Q1 results.
    Nine Energy Service, Inc. (NYSE: NINE) shares climbed 7.4 percent to $35.90.
    Xenon Pharmaceuticals Inc. (NASDAQ: XENE) rose 6.7 percent to $6.40 after the company presented XEN901 Phase 1 clinical update and XEN1101 TMS pharmacodynamic Phase 1 data.
    MYnd
  • [By Max Byerly]

    These are some of the news articles that may have impacted Accern Sentiment Analysis’s analysis:

    Get Innovative Industrial Properties alerts:

    Return on Equity (ROE) under Consideration Innovative Industrial Properties, Inc. (NYSE:IIPR), Neonode Inc … (stocksnewspoint.com) Morning Miraculous Stocks: Taseko Mines Limited (NYSE:TGB), WMIH Corp. (NASDAQ:WMIH), Innovative Industrial … (journalfinance.net) Dazzling Stocks: Innovative Industrial Properties, Inc. (NYSE:IIPR), SORL Auto Parts, Inc. (NASDAQ:SORL), ReWalk … (thestreetpoint.com) Head-To-Head Contrast: Kennedy-Wilson (KW) vs. Innovative Industrial Properties (IIPR) (americanbankingnews.com) Innovative Industrial (IIPR) versus Colliers International Group (CIGI) Financial Contrast (americanbankingnews.com)

    A number of research analysts have weighed in on the company. Zacks Investment Research raised Innovative Industrial Properties from a “sell” rating to a “hold” rating in a report on Friday, March 16th. ValuEngine raised Innovative Industrial Properties from a “hold” rating to a “buy” rating in a report on Wednesday, May 2nd.

Top 10 Casino Stocks To Invest In 2019: County Bancorp, Inc.(ICBK)

Advisors’ Opinion:

  • [By Stephan Byrd]

    County Bancorp Inc (NASDAQ:ICBK) President Timothy J. Schneider sold 1,000 shares of the stock in a transaction on Monday, June 4th. The shares were sold at an average price of $27.55, for a total value of $27,550.00. Following the completion of the sale, the president now owns 113,882 shares in the company, valued at $3,137,449.10. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is available at this link.

  • [By Ethan Ryder]

    Get a free copy of the Zacks research report on County Bancorp (ICBK)

    For more information about research offerings from Zacks Investment Research, visit Zacks.com

  • [By Shane Hupp]

    Guaranty Bancorp (NASDAQ:GBNK) and County Bancorp (NASDAQ:ICBK) are both small-cap finance companies, but which is the superior investment? We will contrast the two companies based on the strength of their profitability, earnings, valuation, analyst recommendations, dividends, risk and institutional ownership.

Top 10 Casino Stocks To Invest In 2019: Retail Opportunity Investments Corp.(ROIC)

Advisors’ Opinion:

  • [By Reuben Gregg Brewer]

    Shares of real estate investment trust Retail Opportunity Investments Corp. (NASDAQ:ROIC) jumped 10% in January, according to data from S&P Global Market Intelligence. That beat the gain of about 8% from the S&P 500 Index, but it was a tad behind the broader REIT sector’s advance of a little under 12%.

  • [By Ethan Ryder]

    First Republic Investment Management Inc. acquired a new position in shares of Retail Opportunity Investments Corp (NASDAQ:ROIC) during the 2nd quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission. The firm acquired 383,325 shares of the real estate investment trust’s stock, valued at approximately $7,345,000. First Republic Investment Management Inc. owned about 0.34% of Retail Opportunity Investments at the end of the most recent reporting period.

  • [By Stephan Byrd]

    Media headlines about Retail Opportunity Investments (NASDAQ:ROIC) have trended somewhat positive this week, Accern reports. The research group identifies negative and positive media coverage by reviewing more than 20 million news and blog sources in real-time. Accern ranks coverage of companies on a scale of negative one to positive one, with scores closest to one being the most favorable. Retail Opportunity Investments earned a news impact score of 0.11 on Accern’s scale. Accern also gave news stories about the real estate investment trust an impact score of 47.8157015849961 out of 100, indicating that recent media coverage is somewhat unlikely to have an impact on the stock’s share price in the immediate future.

Top 10 Casino Stocks To Invest In 2019: International Game Technology(IGT)

Advisors’ Opinion:

  • [By Lee Jackson]

    This company was hit since doing a secondary in which a large shareholder did a forward sale, and it is offering a great entry point. International Game Technology PLC (NYSE: IGT) is the global leader in gaming. The company enables players to experience their favorite games across all channels and regulated segments, from Gaming Machines and Lotteries to Interactive and Social Gaming.

  • [By Lee Jackson]

    This company was hit since doing a secondary in which a large shareholder did a forward sale, and it is offering a great entry point. International Game Technology PLC (NYSE: IGT) is the global leader in gaming. The company enables players to experience their favorite games across all channels and regulated segments, from Gaming Machines and Lotteries to Interactive and Social Gaming.

  • [By Ethan Ryder]

    International Game Technology PLC (NYSE:IGT) has been assigned an average rating of “Buy” from the eight brokerages that are currently covering the firm, Marketbeat.com reports. Two research analysts have rated the stock with a hold rating and six have given a buy rating to the company. The average twelve-month price objective among analysts that have issued a report on the stock in the last year is $32.00.

  • [By Joseph Griffin]

    Paloma Partners Management Co acquired a new position in shares of International Game Technology PLC (NYSE:IGT) during the 2nd quarter, according to its most recent 13F filing with the Securities & Exchange Commission. The firm acquired 20,232 shares of the company’s stock, valued at approximately $470,000.

  • [By Stephan Byrd]

    International Game Technology PLC (NYSE:IGT) shares hit a new 52-week low on Friday . The stock traded as low as $17.17 and last traded at $17.23, with a volume of 326419 shares. The stock had previously closed at $18.47.

Top 10 Casino Stocks To Invest In 2019: Endocyte, Inc.(ECYT)

Advisors’ Opinion:

  • [By Keith Speights]

    Shares of Innovate Biopharmaceuticals (NASDAQ:INNT), Arrowhead Pharmaceuticals (NASDAQ:ARWR), and Endocyte (NASDAQ:ECYT) have more than tripled in the first six months of 2018. What caused these biotech stocks to skyrocket — and are they still buys now?  

  • [By ]

    Exploding biotech names are nothing new to this bull market. You might recall the headline swirling around Endocyte Inc. (NASDAQ:ECYT) as it posted one-day gains of more than 150% during the fourth quarter. The triple-digit move was sparked by a licensing agreement for the firm’s phase 3 prostate cancer drug. Now, these moves are becoming almost commonplace.

  • [By Chris Lange]

    Endocyte Inc. (NASDAQ: ECYT) shares made a solid gain early on Monday after the company announced an update from the U.S. Food and Drug Administration (FDA).

Best Insurance Stocks To Own For 2019

Amarillo National Bank raised its position in iShares S&P 500 Value ETF (NYSEARCA:IVE) by 5.7% during the 3rd quarter, HoldingsChannel.com reports. The institutional investor owned 123,840 shares of the company’s stock after buying an additional 6,639 shares during the quarter. iShares S&P 500 Value ETF comprises about 6.7% of Amarillo National Bank’s portfolio, making the stock its 4th largest holding. Amarillo National Bank’s holdings in iShares S&P 500 Value ETF were worth $14,346,000 at the end of the most recent quarter.

A number of other hedge funds have also recently added to or reduced their stakes in the business. Northern Trust Corp grew its holdings in shares of iShares S&P 500 Value ETF by 12.9% during the 1st quarter. Northern Trust Corp now owns 58,230 shares of the company’s stock valued at $6,367,000 after purchasing an additional 6,650 shares during the last quarter. Blair William & Co. IL grew its holdings in shares of iShares S&P 500 Value ETF by 5.6% during the 1st quarter. Blair William & Co. IL now owns 15,855 shares of the company’s stock valued at $1,734,000 after purchasing an additional 834 shares during the last quarter. The Manufacturers Life Insurance Company grew its holdings in shares of iShares S&P 500 Value ETF by 22.2% during the 1st quarter. The Manufacturers Life Insurance Company now owns 154,815 shares of the company’s stock valued at $16,928,000 after purchasing an additional 28,085 shares during the last quarter. Ancora Advisors LLC bought a new stake in shares of iShares S&P 500 Value ETF during the 1st quarter valued at approximately $244,000. Finally, Jane Street Group LLC grew its holdings in shares of iShares S&P 500 Value ETF by 140.7% during the 1st quarter. Jane Street Group LLC now owns 2,358 shares of the company’s stock valued at $258,000 after purchasing an additional 8,153 shares during the last quarter.

Best Insurance Stocks To Own For 2019: TG Therapeutics, Inc.(TGTX)

Advisors’ Opinion:

  • [By Ethan Ryder]

    Get a free copy of the Zacks research report on TG Therapeutics (TGTX)

    For more information about research offerings from Zacks Investment Research, visit Zacks.com

  • [By George Budwell]

    Shares of the B-cell malignancy and autoimmune disease specialist TG Therapeutics (NASDAQ:TGTX) fell by an eye-popping 55.9% last month, according to data from S&P Global Market Intelligence. What triggered this dramatic sell-off?

  • [By Logan Wallace]

    Get a free copy of the Zacks research report on TG Therapeutics Inc common stock (TGTX)

    For more information about research offerings from Zacks Investment Research, visit Zacks.com

Best Insurance Stocks To Own For 2019: Endocyte, Inc.(ECYT)

Advisors’ Opinion:

  • [By Cory Renauer]

    If these high-flying drugmakers are going to continue their climb, they have to cross some well-defined hurdles in front of them. Here’s a look at what’s ahead.

    Company (Symbol) 1-Year Gain Recent Market Cap
    Arrowhead Pharmaceuticals, Inc. (NASDAQ:ARWR) 535% $1.8 billion
    Viking Therapeutics, Inc. (NASDAQ:VKTX) 880% $725 million
    Endocyte, Inc. (NASDAQ:ECYT) 1,140% $1.2 billion

    Data source: Yahoo! Finance.

  • [By ]

    Exploding biotech names are nothing new to this bull market. You might recall the headline swirling around Endocyte Inc. (NASDAQ:ECYT) as it posted one-day gains of more than 150% during the fourth quarter. The triple-digit move was sparked by a licensing agreement for the firm’s phase 3 prostate cancer drug. Now, these moves are becoming almost commonplace.

  • [By Logan Wallace]

    Get a free copy of the Zacks research report on Endocyte (ECYT)

    For more information about research offerings from Zacks Investment Research, visit Zacks.com

  • [By Logan Wallace]

    Endocyte, Inc. (NASDAQ:ECYT) gapped up prior to trading on Tuesday . The stock had previously closed at $16.70, but opened at $18.00. Endocyte shares last traded at $19.49, with a volume of 145358 shares changing hands.

  • [By Stephan Byrd]

    Get a free copy of the Zacks research report on Endocyte (ECYT)

    For more information about research offerings from Zacks Investment Research, visit Zacks.com

  • [By Keith Speights]

    Shares of Innovate Biopharmaceuticals (NASDAQ:INNT), Arrowhead Pharmaceuticals (NASDAQ:ARWR), and Endocyte (NASDAQ:ECYT) have more than tripled in the first six months of 2018. What caused these biotech stocks to skyrocket — and are they still buys now?  

Best Insurance Stocks To Own For 2019: VOC Energy Trust(VOC)

Advisors’ Opinion:

  • [By Shane Hupp]

    Deutsche Bank AG reduced its position in VOC Energy Trust (NYSE:VOC) by 64.5% in the 4th quarter, Holdings Channel reports. The firm owned 19,000 shares of the oil and gas producer’s stock after selling 34,500 shares during the period. Deutsche Bank AG’s holdings in VOC Energy Trust were worth $112,000 as of its most recent filing with the SEC.

Top 10 Heal Care Stocks To Own Right Now

In this article, I present the technical and fundamental metrics of the stock to conclude that JPM is rich in valuations and even though it may extend its rally, one must not make fresh investments at the current level. I will also provide a safer investing level for investors to consider.

I first discussed JPMorgan Chase & Co (NYSE: JPM) in my August article titled Bank On Banking Stocks To Make You Money in which I contended that,

“Recently, JPM shares entered into a contracting range, but from the looks of it, the stock may have pierced the resistance and is ready to revisit its all-time highs (and maybe higher). Indicators remain supportive, and further strengthen the bullish outlook.”

At that time, JPM was trading close to $65 per share and today it is trading close to all-time highs at $86.29. This is a fabulous return of more than 30 percent in less than 6 months.

Top 10 Heal Care Stocks To Own Right Now: OUTFRONT Media Inc.(OUT)

Advisors’ Opinion:

  • [By Stephan Byrd]

    Hourglass Capital LLC lifted its stake in Outfront Media (NYSE:OUT) by 34.3% during the 1st quarter, according to its most recent disclosure with the SEC. The institutional investor owned 289,617 shares of the financial services provider’s stock after buying an additional 73,964 shares during the quarter. Hourglass Capital LLC owned approximately 0.21% of Outfront Media worth $5,427,000 at the end of the most recent reporting period.

  • [By Logan Wallace]

    Outfront Media (NYSE:OUT) has earned a consensus rating of “Hold” from the six analysts that are presently covering the firm, Marketbeat.com reports. Two research analysts have rated the stock with a sell recommendation, one has assigned a hold recommendation and three have given a buy recommendation to the company. The average twelve-month price target among brokerages that have issued ratings on the stock in the last year is $27.00.

  • [By Joseph Griffin]

    Get a free copy of the Zacks research report on Outfront Media (OUT)

    For more information about research offerings from Zacks Investment Research, visit Zacks.com

  • [By Jeremy Bowman]

    Shares of Outfront Media Inc. (NYSE:OUT) were falling on Thursday after the outdoor advertising specialist released a disappointing second-quarter earnings report. As a result, the stock was down 9% as of 3:10 p.m. EDT.

  • [By Joseph Griffin]

    Get a free copy of the Zacks research report on Outfront Media (OUT)

    For more information about research offerings from Zacks Investment Research, visit Zacks.com

  • [By Lisa Levin] Gainers
    Sanmina Corp (NASDAQ: SANM) shares rose 15.2 percent to $31.90 in pre-market trading as the company reported stronger-than-expected earnings for its second quarter on Monday.
    Cadence Design Systems, Inc. (NASDAQ: CDNS) rose 12.4 percent to $41.30 in pre-market trading after the company posted upbeat Q1 results and issued a strong Q2 forecast.
    Aeglea BioTherapeutics, Inc. (NASDAQ: AGLE) rose 10.8 percent to $8.75 in pre-market trading.
    Mitel Networks Corporation (NASDAQ: MITL) rose 8.8 percent to $11.05 in pre-market trading after the company agreed to be acquired by affiliates of Searchlight Capital Partners for $2.0 billion.
    Galectin Therapeutics, Inc. (NASDAQ: GALT) rose 7.3 percent to $3.70 in pre-market trading.
    Riot Blockchain, Inc. (NASDAQ: RIOT) shares rose 6.9 percent to $7.00 in pre-market trading after declining 1.50 percent on Monday.
    Hallmark Financial Services, Inc. (NASDAQ: HALL) rose 6.5 percent to $10.68 in pre-market trading.
    Boot Barn Holdings, Inc. (NYSE: BOOT) rose 5.2 percent to $20.40 in pre-market trading after gaining 4.53 percent on Monday.
    New Oriental Education & Technology Group Inc. (NYSE: EDU) rose 5 percent to $91.16 in pre-market trading after reporting Q3 results.
    Shire plc (NASDAQ: SHPG) rose 5 percent to $167.98 in pre-market trading after Bloomberg reported that Takeda is nearing a preliminary agreement to acquire Shire after sweetened bid.
    Outfront Media Inc. (NYSE: OUT) shares rose 5 percent to $19.00 in pre-market trading.
    Geron Corporation (NASDAQ: GERN) rose 4.3 percent to $4.18 in pre-market trading after gaining 5.80 percent on Monday.
    SAP SE (NYSE: SAP) rose 3.7 percent to $109.80 in pre-market trading after the company posted strong quarterly results and raised its outlook for the year.
    Golden Ocean Group Limited (NASDAQ: GOGL) shares rose 3.7 percent to $8.70 in pre-market trading after gaining 1.45 percent on Monday.
    Deutsche Bank Aktiengesellschaft (NYSE: D

Top 10 Heal Care Stocks To Own Right Now: Endocyte, Inc.(ECYT)

Advisors’ Opinion:

  • [By Logan Wallace]

    Get a free copy of the Zacks research report on Endocyte (ECYT)

    For more information about research offerings from Zacks Investment Research, visit Zacks.com

  • [By Logan Wallace]

    Endocyte, Inc. (NASDAQ:ECYT) gapped up prior to trading on Tuesday . The stock had previously closed at $16.70, but opened at $18.00. Endocyte shares last traded at $19.49, with a volume of 145358 shares changing hands.

  • [By Keith Speights]

    Shares of Innovate Biopharmaceuticals (NASDAQ:INNT), Arrowhead Pharmaceuticals (NASDAQ:ARWR), and Endocyte (NASDAQ:ECYT) have more than tripled in the first six months of 2018. What caused these biotech stocks to skyrocket — and are they still buys now?  

Top 10 Heal Care Stocks To Own Right Now: Capital Trust, Inc.(BXMT)

Advisors’ Opinion:

  • [By WWW.GURUFOCUS.COM]

    For the details of Delphi Financial Group Inc’s stock buys and sells, go to www.gurufocus.com/StockBuy.php?GuruName=Delphi+Financial+Group+Inc

    These are the top 5 holdings of Delphi Financial Group IncTwo Harbors Investment Corp (TWO) – 3,751,809 shares, 23.18% of the total portfolio. Energy Transfer Equity LP (ETE) – 2,979,000 shares, 20.1% of the total portfolio. Shares added by 91.45%Energy Transfer Partners LP (ETP) – 2,690,074 shares, 20.02% of the total portfolio. TPG Specialty Lending Inc (TSLX) – 1,482,024 shares, 10.4% of the total portfolio. Shares added by 4.83%Blackstone Mortgage Trust Inc (BXMT) – 773,226 shares, 9.5% of the total portfolio. Shares added b

Top 10 Heal Care Stocks To Own Right Now: Valspar Corporation (VAL)

Advisors’ Opinion:

  • [By Max Byerly]

    Valorbit (CURRENCY:VAL) traded 0% higher against the dollar during the 1 day period ending at 11:00 AM Eastern on June 9th. One Valorbit coin can currently be bought for approximately $0.0001 or 0.00000001 BTC on exchanges. Valorbit has a market cap of $537,598.00 and $0.00 worth of Valorbit was traded on exchanges in the last 24 hours. In the last seven days, Valorbit has traded up 5.8% against the dollar.

  • [By Stephan Byrd]

    Valorbit (CURRENCY:VAL) traded up 0% against the U.S. dollar during the 1 day period ending at 0:00 AM E.T. on June 18th. One Valorbit coin can now be bought for approximately $0.0001 or 0.00000001 BTC on popular exchanges. Valorbit has a total market capitalization of $537,598.00 and $0.00 worth of Valorbit was traded on exchanges in the last day. During the last week, Valorbit has traded 5.8% higher against the U.S. dollar.

  • [By Shane Hupp]

    Shares of ValiRx Plc (LON:VAL) rose 5.6% during mid-day trading on Thursday . The company traded as high as GBX 1.90 ($0.02) and last traded at GBX 1.90 ($0.02). Approximately 587,748 shares were traded during trading, a decline of 85% from the average daily volume of 3,820,000 shares. The stock had previously closed at GBX 1.80 ($0.02).

Top 10 Heal Care Stocks To Own Right Now: E-House(China)

Advisors’ Opinion:

  • [By ]

    The world’s largest operating utility-scale solar projects are concentrated in China and India, according to IEEFA. Based on company and press reports, as well as its own estimates, those include:

    RankingProject NameSize MWCountryProponent 1Tengger Desert Solar Park1,547ChinaChina National Grid Zhongwei Power Supply Co2Kurnool Ultra Mega Solar Park1,000IndiaAndhra Pradesh Solar Power Corporation Pvt Ltd3Datong Solar Power Top Runner Base1,000ChinaMultiple4Yanchi Ningxia Solar Park1,000ChinaHuawei Technologies Co5Longyangxia Dam Solar Park850ChinaState Power Investment Corporation (China)6Adani Kamuthi Solar Plant648IndiaAdani Green7Solar Star579U.S.BHE Renewables8Topaz Solar Farm550U.S.First Solar9Desert Sunlight Solar Farm550U.S.NextEra Energy, GE Energy Financial & Sumitomo10Nova Olinda Solar Farm292BrazilEnel Green Power

    China added 53 gigawatts of the 98 gigawatts of new solar capacity built last year, a 31 percent increase from the total 2017, IEEFA said, citing Bloomberg New Energy Finance data. Meanwhile, the per unit cost of electricity over the life of a generating asset fell 15 percent year-on-year to $86 a megawatt hour.

Top 10 Heal Care Stocks To Own Right Now: Nuveen Pennsylvania Investment Quality Municipal Fund, Inc.(NQP)

Advisors’ Opinion:

  • [By Garrett Baldwin]

    And we’ve tapped into a secret way to get growth and income thanks to legalized gambling by owning the Nuveen Pennsylvania Quality (NYSE: NQP) closed-end fund.

Top 10 Heal Care Stocks To Own Right Now: Enerplus Corporation(ERF)

Advisors’ Opinion:

  • [By Shane Hupp]

    Get a free copy of the Zacks research report on Enerplus (ERF)

    For more information about research offerings from Zacks Investment Research, visit Zacks.com

  • [By Ethan Ryder]

    Enerplus (NYSE:ERF) (TSE:ERF) – Stock analysts at National Bank Financial reduced their FY2018 earnings estimates for Enerplus in a research note issued on Thursday, May 3rd. National Bank Financial analyst T. Wood now forecasts that the oil and natural gas company will earn $1.13 per share for the year, down from their previous estimate of $1.27. National Bank Financial also issued estimates for Enerplus’ FY2019 earnings at $1.96 EPS.

  • [By Max Byerly]

    Enerplus (TSE:ERF) (NYSE:ERF) had its target price hoisted by CIBC from C$19.00 to C$20.00 in a research note published on Friday morning.

    Other research analysts also recently issued research reports about the stock. CSFB upped their price objective on shares of Enerplus from C$17.00 to C$20.00 in a report on Friday, April 13th. GMP Securities upped their price objective on shares of Enerplus from C$17.00 to C$18.00 in a report on Thursday, March 1st. Barclays upped their price objective on shares of Enerplus from C$18.00 to C$20.00 in a report on Monday, February 26th. Canaccord Genuity upped their price objective on shares of Enerplus from C$16.50 to C$17.00 in a report on Monday, February 26th. Finally, Desjardins upped their price objective on shares of Enerplus from C$16.00 to C$17.50 in a report on Monday, February 26th. Seven equities research analysts have rated the stock with a buy rating, The stock has an average rating of Buy and an average price target of C$18.29.

Top 10 Heal Care Stocks To Own Right Now: AcelRx Pharmaceuticals Inc.(ACRX)

Advisors’ Opinion:

  • [By Chris Lange]

    AcelRx Pharmaceuticals Inc. (NASDAQ: ACRX) announced the Anesthetic and Analgesic Drug Products Advisory Committee of the FDA has a meeting to revenue the company’s New Drug Application (NDA) for Dsuvia for the management of moderate-to-severe acute pain in medically supervised settings in adult patients. The PDUFA date is set for November 3.

  • [By Lisa Levin] Gainers
    Comstock Holding Companies, Inc. (NASDAQ: CHCI) shares surged 115.8 percent to $4.3591. Comstock reported conversion of the majority of its unsecured, short-term debt into non-convertible preferred equity.
    Stellar Biotechnologies, Inc. (NASDAQ: SBOT) jumped 38.2 percent to $3.0251 after the company disclosed that it achieved robust viral clearance for its manufacturing process.
    Universal Corporation (NYSE: UVV) surged 26.7 percent to $61.40 after reporting fiscal Q4 results.
    Hudson Technologies Inc. (NASDAQ: HDSN) rose 18.9 percent to $2.58.
    Evolus, Inc. (NASDAQ: EOLS) shares gained 17.8 percent to $22.8009.
    The Cato Corporation (NYSE: CATO) shares gained 17.5 percent to $21.07 after the company posted better-than-expected first-quarter results.
    Tyme Technologies, Inc. (NASDAQ: TYME) rose 15.9 percent to $3.3613.
    Destination Maternity Corporation (NASDAQ: DEST) shares gained 15.5 percent to $3.35 after the board announced late Wednesday the election of four activist-backed director nominees. Three women and one man comprise the selected group championed by NGM Capital’s Nathan Miller and Kenosis Capital’s Peter O’Malley. Destination Maternity had advocated for another slate of three men and interim CEO Melissa Payner-Gregor. The new directors are Holly Alden, Marla Ryan, Anne-Charlotte Windal and Christopher Morgan.
    AXT, Inc. (NASDAQ: AXTI) rose 15 percent to $7.65.
    nLIGHT, Inc. (NASDAQ: LASR) gained 14.5 percent to $34.27 following Q1 results.
    Achieve Life Sciences, Inc. (NASDAQ: ACHV) rose 14.3 percent to $11.4303.
    Bilibili Inc.. (NASDAQ: BILI) shares climbed 13.9 percent to $14.16 after announcing Q1 results.
    Babcock & Wilcox Enterprises, Inc. (NYSE: BW) gained 13.2 percent to $2.91 after an amended 13D filing from Steel Partners Holdings shows a raised stake in the company from 6.99 million shares to 29.98 million shares, or a 17.8 percent stake.
    HUYA Inc. (NYSE: HUYA) gained 13.1
  • [By Max Byerly]

    Get a free copy of the Zacks research report on AcelRx Pharmaceuticals (ACRX)

    For more information about research offerings from Zacks Investment Research, visit Zacks.com

  • [By Lisa Levin] Gainers
    Stellar Biotechnologies, Inc. (NASDAQ: SBOT) rose 32 percent to $2.89 in pre-market trading after the company disclosed that it achieved robust viral clearance for its manufacturing process.
    Babcock & Wilcox Enterprises, Inc. (NYSE: BW) rose 17.7 percent to $3.03 in pre-market trading after an amended 13D filing from Steel Partners Holdings shows a raised stake in the company from 6.99 million shares to 29.98 million shares, or a 17.8 percent stake.
    AcelRx Pharmaceuticals, Inc. (NASDAQ: ACRX) shares rose 12.7 percent to $3.55 in pre-market trading after the company announced the FDA acceptance of NDA for DSUVIA.
    Williams-Sonoma, Inc. (NYSE: WSM) shares rose 11.7 percent to $54.95 in pre-market trading. after the company reported stronger-than-expected results for its first quarter. The company also raised its FY18 earnings and sales guidance.
    Bilibili Inc. (NASDAQ: BILI) shares rose 9.3 percent to $13.59 in pre-market trading after announcing Q1 results.
    Stein Mart, Inc. (NASDAQ: SMRT) rose 8.1 percent to $3.46 in pre-market trading after reporting strong Q1 earnings.
    Universal Corporation (NYSE: UVV) rose 8.1 percent to $52.35 in pre-market trading after reporting fiscal Q4 results.
    Marinus Pharmaceuticals, Inc. (NASDAQ: MRNS) rose 8.1 percent to $5.65 in pre-market trading after gaining 6.30 percent on Wednesday.
    CEL-SCI Corporation (NYSE: CVM) rose 6.1 percent to $3.30 in pre-market trading after climbing 9.51 percent on Wednesday.
    TransEnterix, Inc. (NYSE: TRXC) rose 6 percent to $3.10 in pre-market trading after reporting a loan deal for $40 million in term loans with Hercules Capital.
    Stage Stores, Inc. (NYSE: SSI) rose 5.6 percent to $3.40 in pre-market trading following Q1 results.
    Koss Corporation (NASDAQ: KOSS) shares rose 5.2 percent to $2.42 in the pre-market trading session after falling 2.54 percent on Wednesday.

     

Top 10 Heal Care Stocks To Own Right Now: Nuance Communications Inc.(NUAN)

Advisors’ Opinion:

  • [By Paul Ausick]

    Nuance Communications Inc. (NASDAQ: NUAN) dropped about 20% Thursday to post a new 52-week low of $12.19. Shares closed at $15.28 on Wednesday and the stock’s 52-week high is $19.49. Volume of around 19 million shares was about nine times the daily average. The company reported indifferent results Wednesday night but cut its outlook for revenue growth.

  • [By Joseph Griffin]

    ValuEngine upgraded shares of Nuance Communications (NASDAQ:NUAN) from a sell rating to a hold rating in a report released on Thursday.

    Several other analysts have also commented on the company. Standpoint Research lowered Nuance Communications from a buy rating to a hold rating in a report on Thursday. Barclays lifted their price target on Nuance Communications from $18.00 to $20.00 and gave the stock an overweight rating in a research note on Thursday. Stifel Nicolaus lifted their price target on Nuance Communications from $15.00 to $17.00 and gave the stock a hold rating in a research note on Thursday. BidaskClub lowered Nuance Communications from a buy rating to a hold rating in a research note on Wednesday, August 1st. Finally, Zacks Investment Research raised Nuance Communications from a sell rating to a hold rating in a research note on Wednesday, July 11th. Six equities research analysts have rated the stock with a hold rating and four have assigned a buy rating to the company’s stock. Nuance Communications currently has an average rating of Hold and a consensus price target of $19.43.

  • [By Max Byerly]

    Nuance Communications Inc. (NASDAQ:NUAN) insider Daniel David Tempesta sold 3,000 shares of Nuance Communications stock in a transaction that occurred on Friday, September 7th. The shares were sold at an average price of $16.75, for a total transaction of $50,250.00. Following the transaction, the insider now directly owns 329,883 shares in the company, valued at $5,525,540.25. The sale was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through the SEC website.

  • [By Ethan Ryder]

    Nuance Communications (NASDAQ:NUAN) had its price objective cut by Stifel Nicolaus from $18.00 to $15.00 in a report issued on Thursday. The brokerage currently has a “hold” rating on the software maker’s stock. Stifel Nicolaus’ target price indicates a potential upside of 15.03% from the company’s current price.

  • [By Rich Smith]

    Shares of Nuance Communications (NASDAQ:NUAN), maker of the popular “Dragon NaturallySpeaking” speech-to-text software, jumped more than 10% in early Thursday trading after the company reported fiscal Q3 2018 earnings results  that broadly met Wall Street’s expectations.

  • [By Dan Caplinger]

    In order to use artificial intelligence effectively, communication is essential, and Nuance Communications (NASDAQ:NUAN) has a long history in the area of letting people use natural language to interact with technology. Yet even though the scope of its addressable market is huge, Nuance hasn’t lived up to its potential. After expending a lot of effort looking outward to try to find the most lucrative opportunities for growth, the tech company decided to refocus its efforts internally. It knows that in order to sustain its competitive advantage, it needs to use its lead to push forward with groundbreaking technological innovations.

Top 10 Heal Care Stocks To Own Right Now: Geo Group Inc (GEO)

Advisors’ Opinion:

  • [By Shane Hupp]

    GeoCoin (GEO) is a token. It launched on August 18th, 2013. GeoCoin’s total supply is 4,000,000 tokens and its circulating supply is 3,170,551 tokens. GeoCoin’s official Twitter account is @geo_coin. The official website for GeoCoin is geocoin.cash.

  • [By Stephan Byrd]

    The GEO Group Inc (NYSE:GEO) Director Richard H. Glanton sold 3,175 shares of the stock in a transaction on Tuesday, August 28th. The shares were sold at an average price of $25.19, for a total value of $79,978.25. Following the completion of the transaction, the director now directly owns 5,252 shares in the company, valued at approximately $132,297.88. The transaction was disclosed in a filing with the SEC, which can be accessed through the SEC website.

  • [By Shane Hupp]

    GeoCoin (CURRENCY:GEO) traded up 2% against the US dollar during the 1 day period ending at 23:00 PM E.T. on June 6th. During the last week, GeoCoin has traded 4.4% lower against the US dollar. GeoCoin has a total market cap of $4.30 million and approximately $4,573.00 worth of GeoCoin was traded on exchanges in the last 24 hours. One GeoCoin token can now be bought for $1.36 or 0.00017563 BTC on cryptocurrency exchanges including Bittrex and Cryptopia.

  • [By Shane Hupp]

    The GEO Group Inc (NYSE:GEO) has earned a consensus recommendation of “Hold” from the six ratings firms that are presently covering the firm, MarketBeat Ratings reports. One investment analyst has rated the stock with a sell recommendation, two have issued a hold recommendation and two have issued a buy recommendation on the company. The average 12-month price target among brokerages that have issued ratings on the stock in the last year is $33.50.

  • [By Rich Duprey, Daniel Miller, and Dan Caplinger]

    ExxonMobil (NYSE:XOM), General Motors (NYSE:GM), and GEO Group (NYSE:GEO) have been identified by three Motley Fool contributors as meeting those criteria. Read on to see why you may want to buy one, two, or all three of them for your own portfolio.

Top 10 Value Stocks To Invest In Right Now

CIBC World Markets Inc. reduced its holdings in B2Gold Corp. (NYSEAMERICAN:BTG) (TSE:BTO) by 10.2% during the 1st quarter, according to its most recent disclosure with the Securities and Exchange Commission (SEC). The firm owned 572,525 shares of the basic materials company’s stock after selling 64,714 shares during the period. CIBC World Markets Inc. owned approximately 0.06% of B2Gold worth $1,563,000 as of its most recent SEC filing.

A number of other hedge funds and other institutional investors have also made changes to their positions in the stock. Van ECK Associates Corp lifted its holdings in B2Gold by 1.2% in the first quarter. Van ECK Associates Corp now owns 118,233,905 shares of the basic materials company’s stock valued at $322,829,000 after buying an additional 1,409,132 shares during the period. Royal Bank of Canada lifted its holdings in B2Gold by 0.5% in the first quarter. Royal Bank of Canada now owns 24,202,109 shares of the basic materials company’s stock valued at $66,073,000 after buying an additional 113,717 shares during the period. Renaissance Technologies LLC lifted its holdings in B2Gold by 7.3% in the fourth quarter. Renaissance Technologies LLC now owns 11,430,397 shares of the basic materials company’s stock valued at $35,433,000 after buying an additional 779,900 shares during the period. OppenheimerFunds Inc. lifted its holdings in B2Gold by 4.8% in the first quarter. OppenheimerFunds Inc. now owns 11,300,000 shares of the basic materials company’s stock valued at $30,849,000 after buying an additional 520,000 shares during the period. Finally, First Eagle Investment Management LLC lifted its holdings in B2Gold by 26.0% in the first quarter. First Eagle Investment Management LLC now owns 9,700,300 shares of the basic materials company’s stock valued at $26,577,000 after buying an additional 2,000,000 shares during the period.

Top 10 Value Stocks To Invest In Right Now: Airgas Inc.(ARG)

Advisors’ Opinion:

  • [By Stephan Byrd]

    Argentum (CURRENCY:ARG) traded 3.6% lower against the US dollar during the one day period ending at 19:00 PM ET on May 27th. In the last week, Argentum has traded 2.8% lower against the US dollar. Argentum has a total market capitalization of $1.66 million and approximately $610.00 worth of Argentum was traded on exchanges in the last day. One Argentum coin can currently be purchased for about $0.17 or 0.00002374 BTC on popular cryptocurrency exchanges including Cryptopia and CoinExchange.

Top 10 Value Stocks To Invest In Right Now: Vanda Pharmaceuticals Inc.(VNDA)

Advisors’ Opinion:

  • [By Stephan Byrd]

    Shares of Vanda Pharmaceuticals Inc. (NASDAQ:VNDA) have been assigned an average recommendation of “Buy” from the eight ratings firms that are covering the stock, Marketbeat reports. One research analyst has rated the stock with a hold recommendation and seven have issued a buy recommendation on the company. The average 1-year price target among brokerages that have covered the stock in the last year is $22.40.

  • [By Stephan Byrd]

    Media stories about Vanda Pharmaceuticals (NASDAQ:VNDA) have trended somewhat positive on Thursday, Accern Sentiment Analysis reports. The research group identifies positive and negative media coverage by monitoring more than twenty million blog and news sources. Accern ranks coverage of publicly-traded companies on a scale of -1 to 1, with scores nearest to one being the most favorable. Vanda Pharmaceuticals earned a media sentiment score of 0.09 on Accern’s scale. Accern also gave media coverage about the biopharmaceutical company an impact score of 46.3857713397213 out of 100, meaning that recent media coverage is somewhat unlikely to have an impact on the company’s share price in the next several days.

  • [By Stephan Byrd]

    Get a free copy of the Zacks research report on Vanda Pharmaceuticals (VNDA)

    For more information about research offerings from Zacks Investment Research, visit Zacks.com

Top 10 Value Stocks To Invest In Right Now: Calavo Growers, Inc.(CVGW)

Advisors’ Opinion:

  • [By Peter Graham]

    Small cap avocado and fresh food stock Calavo Growers (NASDAQ: CVGW) has elevated short interest of 33.51% according to Highshortinterest.com. Founded in 1924, Calavo Growers is a global avocado-industry leader and an expanding provider of value-added fresh food serving retail grocery, foodservice, club stores, mass merchandisers, food distributors and wholesalers worldwide. The Companys Fresh segment procures and markets fresh avocados and select other fresh produce (tomatoes) while the Renaissance Food Group segment (RFG) creates, markets and distributes a portfolio of healthy, fresh foods, including fresh-cut fruit, fresh-cut vegetables and prepared foods. The Foods segment manufactures and distributes guacamole and salsa. Fresh food products are sold under the respected Calavo brand name as well as Garden Highway, Chef Essentials and a variety of private label and store brands.

  • [By Max Byerly]

    Get a free copy of the Zacks research report on Calavo Growers (CVGW)

    For more information about research offerings from Zacks Investment Research, visit Zacks.com

  • [By Ethan Ryder]

    Prudential Financial Inc. raised its holdings in shares of Calavo Growers (NASDAQ:CVGW) by 5.9% during the first quarter, HoldingsChannel.com reports. The firm owned 28,216 shares of the company’s stock after acquiring an additional 1,580 shares during the quarter. Prudential Financial Inc.’s holdings in Calavo Growers were worth $2,602,000 at the end of the most recent quarter.

  • [By Asit Sharma]

    Calavo Growers, Inc. (NASDAQ:CVGW), which I’ve dubbed a “tiny, mighty dividend stock,” reported fiscal second-quarter 2018 earnings on June 6. How has this dynamic avocado market specialist fared so far in its fiscal year? Let’s dive into the quarter’s detailsafter first walking through headline numbers directly below.

Top 10 Value Stocks To Invest In Right Now: Macatawa Bank Corporation(MCBC)

Advisors’ Opinion:

  • [By Max Byerly]

    Chemical Financial (NASDAQ: CHFC) and Macatawa Bank (NASDAQ:MCBC) are both finance companies, but which is the better business? We will contrast the two businesses based on the strength of their dividends, earnings, institutional ownership, analyst recommendations, valuation, profitability and risk.

  • [By Ethan Ryder]

    BidaskClub upgraded shares of Macatawa Bank (NASDAQ:MCBC) from a buy rating to a strong-buy rating in a research note released on Friday morning.

    Separately, Hovde Group set a $11.00 price target on Macatawa Bank and gave the stock a hold rating in a research report on Monday, January 29th.

Top 10 Value Stocks To Invest In Right Now: Aquinox Pharmaceuticals, Inc.(AQXP)

Advisors’ Opinion:

  • [By Max Byerly]

    Shares of Aquinox Pharmaceuticals Inc (NASDAQ:AQXP) have received an average recommendation of “Buy” from the seven research firms that are covering the firm, MarketBeat reports. Three analysts have rated the stock with a hold rating and four have issued a buy rating on the company. The average 1 year target price among brokers that have covered the stock in the last year is $25.25.

  • [By Ethan Ryder]

    Cantor Fitzgerald reiterated their neutral rating on shares of Aquinox Pharmaceuticals (NASDAQ:AQXP) in a research report report published on Wednesday, MarketBeat.com reports.

  • [By Paul Ausick]

    Aquinox Pharmaceuticals Inc. (NASDAQ: AQXP) dropped about nearly 85% Wednesday to post a new 52-week low of $2.25. Shares closed at $15.31 on Tuesday and the stock’s 52-week high is $16.90. Volume totaled 13.5 million shares compared to a daily average of less than 200,000. The company’s bladder pain drug failed a trial and the company is stopping development.

  • [By Logan Wallace]

    Aquinox Pharmaceuticals (NASDAQ:AQXP) was downgraded by stock analysts at ValuEngine from a “hold” rating to a “sell” rating in a report released on Monday.

Top 10 Value Stocks To Invest In Right Now: Pioneer Floating Rate Trust(PHD)

Advisors’ Opinion:

  • [By Ethan Ryder]

    News headlines about Pioneer Floating Rate Trust (NYSE:PHD) have trended somewhat positive on Thursday, Accern reports. The research firm rates the sentiment of media coverage by analyzing more than twenty million news and blog sources in real-time. Accern ranks coverage of companies on a scale of -1 to 1, with scores nearest to one being the most favorable. Pioneer Floating Rate Trust earned a media sentiment score of 0.09 on Accern’s scale. Accern also assigned media headlines about the investment management company an impact score of 46.8710327510951 out of 100, indicating that recent media coverage is somewhat unlikely to have an effect on the company’s share price in the next few days.

Top 10 Value Stocks To Invest In Right Now: Concho Resources Inc.(CXO)

Advisors’ Opinion:

  • [By Ethan Ryder]

    Tredje AP fonden grew its stake in Concho Resources (NYSE:CXO) by 4.4% during the 1st quarter, according to its most recent disclosure with the Securities and Exchange Commission. The institutional investor owned 13,417 shares of the oil and natural gas company’s stock after acquiring an additional 560 shares during the quarter. Tredje AP fonden’s holdings in Concho Resources were worth $2,017,000 at the end of the most recent quarter.

  • [By Chris Lange]

    The S&P 500 stock posting the largest daily percentage loss ahead of the close Wednesday was Concho Resources Inc. (NYSE: CXO) which traded down about 9% at $143.15. The stocks 52-week range is $106.73 to $162.91. Volume was 11.8 million compared to the daily average volume of 1.3 million.

  • [By ]

    The hot list:

    Align Technology (ALGN) (+22% revenue growth estimate) Amazon (AMZN) (+22%) Autodesk (ADSK) (+27%) Cabot Oil & Gas (COG) (+34%) Concho Resources (CXO) (+30%) Facebook (FB) (+27%) Netflix (NFLX) (+25%) Pentair (PNR) (+22%) Vertex Pharmaceuticals (VRTX) (+22)

    “Firms with high revenue growth should outperform the S&P 500 during the next 12 months as the index climbs by 6% to our target of 2875,” says Kostin. 

  • [By Matthew DiLallo]

    Oil has continued its remarkable rise this year, rallying another 10%, to more than $65 a barrel in the U.S. That rebound has taken most oil stocks up with it. However, a handful managed to lose ground this year, including Laredo Petroleum (NYSE:LPI), Concho Resources (NYSE:CXO), and Cimarex Energy (NYSE:XEC), which are all down double digits. That sell-off makes them worth a closer look.

Top 10 Value Stocks To Invest In Right Now: PACCAR Inc.(PCAR)

Advisors’ Opinion:

  • [By Lisa Levin] Companies Reporting Before The Bell
    United Technologies Corporation (NYSE: UTX) is estimated to report quarterly earnings at $1.51 per share on revenue of $14.62 billion.
    The Coca-Cola Company (NYSE: KO) is expected to report quarterly earnings at $0.46 per share on revenue of $7.31 billion.
    Caterpillar Inc. (NYSE: CAT) is projected to report quarterly earnings at $2.07 per share on revenue of $11.93 billion.
    Verizon Communications Inc. (NYSE: VZ) is expected to report quarterly earnings at $1.11 per share on revenue of $31.22 billion.
    Lockheed Martin Corporation (NYSE: LMT) is estimated to report quarterly earnings at $3.42 per share on revenue of $11.28 billion.
    The Sherwin-Williams Company (NYSE: SHW) is projected to report quarterly earnings at $3.15 per share on revenue of $3.94 billion.
    Biogen Inc. (NASDAQ: BIIB) is expected to report quarterly earnings at $5.92 per share on revenue of $3.15 billion.
    3M Company (NYSE: MMM) is estimated to report quarterly earnings at $2.52 per share on revenue of $8.26 billion.
    JetBlue Airways Corporation (NASDAQ: JBLU) is projected to report quarterly earnings at $0.2 per share on revenue of $1.75 billion.
    Eli Lilly and Company (NYSE: LLY) is expected to report quarterly earnings at $1.13 per share on revenue of $5.49 billion.
    Harley-Davidson, Inc. (NYSE: HOG) is estimated to report quarterly earnings at $0.88 per share on revenue of $1.25 billion.
    Corning Incorporated (NYSE: GLW) is expected to report quarterly earnings at $0.3 per share on revenue of $2.50 billion.
    Centene Corporation (NYSE: CNC) is projected to report quarterly earnings at $1.88 per share on revenue of $13.28 billion.
    The Travelers Companies, Inc. (NYSE: TRV) is estimated to report quarterly earnings at $2.77 per share on revenue of $6.75 billion.
    Wipro Limited (NYSE: WIT) is expected to report quarterly earnings at $0.07 per share on revenue of $2.16 billion.
    PACCAR Inc (NASDAQ: PCAR) is projected to
  • [By Shane Hupp]

    BidaskClub downgraded shares of PACCAR (NASDAQ:PCAR) from a sell rating to a strong sell rating in a research report released on Saturday morning.

    Several other analysts also recently weighed in on the company. JPMorgan Chase & Co. lowered their price objective on PACCAR from $74.00 to $72.00 and set a hold rating for the company in a research report on Tuesday, April 10th. Deutsche Bank downgraded PACCAR from a hold rating to a sell rating and set a $77.00 price objective for the company. in a research report on Monday, March 19th. Zacks Investment Research downgraded PACCAR from a buy rating to a hold rating in a research report on Tuesday, April 3rd. ValuEngine upgraded PACCAR from a hold rating to a buy rating in a research report on Tuesday, April 3rd. Finally, Robert W. Baird reiterated a hold rating and issued a $80.00 price objective on shares of PACCAR in a research report on Tuesday, April 17th. Five investment analysts have rated the stock with a sell rating, fifteen have given a hold rating and five have issued a buy rating to the company. The company has a consensus rating of Hold and a consensus price target of $73.30.

  • [By Max Byerly]

    New York State Teachers Retirement System decreased its position in shares of Paccar (NASDAQ:PCAR) by 0.3% during the 1st quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The firm owned 535,919 shares of the company’s stock after selling 1,577 shares during the period. New York State Teachers Retirement System owned about 0.15% of Paccar worth $35,462,000 at the end of the most recent reporting period.

  • [By Logan Wallace]

    Hudson Capital Management LLC grew its position in shares of PACCAR Inc (NASDAQ:PCAR) by 8.5% in the 2nd quarter, according to the company in its most recent filing with the Securities and Exchange Commission (SEC). The fund owned 22,965 shares of the company’s stock after buying an additional 1,798 shares during the quarter. Hudson Capital Management LLC’s holdings in PACCAR were worth $1,423,000 as of its most recent filing with the Securities and Exchange Commission (SEC).

  • [By ]

    “Companies ranging from Action Alerts PLUS holding Microsoft (MSFT)  to heavy-truck maker Paccar (PCAR)  have over the years declared so-called ‘special dividends’ — one-time extra payments to shareholders. With the new U.S. tax law granting corporations a limited window to repatriate overseas profits at low tax rates, many companies might use the extra cash for special dividends. Let’s discuss how this impacts income investors,” writes Real Money Pro columnist Christopher Versace.

Top 10 Value Stocks To Invest In Right Now: Malibu Boats, Inc.(MBUU)

Advisors’ Opinion:

  • [By Rich Duprey]

    The latter will put Polaris in competition with leading powerboat manufacturer Malibu Boats (NASDAQ:MBUU), which last year bought Cobalt Boats, the top maker of 24- to 29-foot sterndrive boats.

  • [By Ethan Ryder]

    Get a free copy of the Zacks research report on Malibu Boats (MBUU)

    For more information about research offerings from Zacks Investment Research, visit Zacks.com

  • [By Stephan Byrd]

    Get a free copy of the Zacks research report on Malibu Boats (MBUU)

    For more information about research offerings from Zacks Investment Research, visit Zacks.com

Top 10 Value Stocks To Invest In Right Now: Endocyte, Inc.(ECYT)

Advisors’ Opinion:

  • [By Shane Hupp]

    Get a free copy of the Zacks research report on Endocyte (ECYT)

    For more information about research offerings from Zacks Investment Research, visit Zacks.com

  • [By Brian Orelli]

    Shares of Endocyte (NASDAQ:ECYT) are up 7.5% as of 12:11 p.m. EDT, having been up as much as 18% today, after the biotech releasedupdated data from its phase 2 trial testing 177Lu-PSMA-617. It will be presented at the American Society of Clinical Oncology (ASCO) annual meeting next month.

  • [By Joseph Griffin]

    Endocyte (NASDAQ:ECYT) is set to release its earnings data after the market closes on Monday, May 7th. Analysts expect Endocyte to post earnings of ($0.19) per share for the quarter.

  • [By Logan Wallace]

    Get a free copy of the Zacks research report on Endocyte (ECYT)

    For more information about research offerings from Zacks Investment Research, visit Zacks.com

  • [By Logan Wallace]

    Get a free copy of the Zacks research report on Endocyte (ECYT)

    For more information about research offerings from Zacks Investment Research, visit Zacks.com

Top Heal Care Stocks To Buy Right Now

Boston Dynamics’ robots keep getting smarter — and soon they’ll be available for purchase.

At a TechCrunch robotics event on Friday, Boston Dynamics founder Marc Raibert announced its robotic dog SpotMini is currently in “pre-production.” The company will start selling the robots in 2019.

It’s unclear who will be able to buy them, and the cost has not yet been revealed.

“SpotMini is in pre-production now,” Raibert said. “We’ve built 10 units [of] a design that’s close to [what] a manufacture will design. We’ve built them in house but with help from contractor/manufacture type people.”

The dog-like SpotMini robot climbs up and down stairs. The first version of the SpotMini walked, rolled over and even put objects in a dishwasher. Last year, it was revamped and can now walk by itself using autonomous navigation. Earlier this year, Boston Dynamics released a video showing the SpotMini opening a door for another robot.

The SpotMini robot

At Amazon’s robotic conference earlier this year, CEO Jeff Bezos posted a photo of him walking with one of the Boston Dynamics robot dogs.

Top Heal Care Stocks To Buy Right Now: Lumber Liquidators Holdings, Inc(LL)

Advisors’ Opinion:

  • [By Ethan Ryder]

    Lumber Liquidators Holdings (NYSE:LL) – Oppenheimer upped their FY2018 earnings per share (EPS) estimates for shares of Lumber Liquidators in a report issued on Tuesday, May 1st. Oppenheimer analyst B. Nagel now forecasts that the specialty retailer will post earnings of $0.80 per share for the year, up from their prior estimate of $0.70.

Top Heal Care Stocks To Buy Right Now: Franklin Resources, Inc.(BEN)

Advisors’ Opinion:

  • [By Paul Ausick]

    Franklin Resources Inc. (NYSE: BEN) traded down about 2% Wednesday to post a new 52-week low of $32.41 after closing Tuesday at $33.09. The stock’s 52-week high is $47.65. Volume was about equal to the daily average of around 3.6 million shares. The company had no specific news Wednesday.

  • [By WWW.GURUFOCUS.COM]

    For the details of Gallagher Fiduciary Advisors, LLC’s stock buys and sells, go to www.gurufocus.com/StockBuy.php?GuruName=Gallagher+Fiduciary+Advisors%2C+LLC

    These are the top 5 holdings of Gallagher Fiduciary Advisors, LLCFifth Third Bancorp (FITB) – 7,424,558 shares, 43.91% of the total portfolio. New PositionUnited States Steel Corp (X) – 3,763,643 shares, 25.82% of the total portfolio. Franklin Resources Inc (BEN) – 1,825,092 shares, 15.42% of the total portfolio. Shares reduced by 2.44%Cleveland-Cliffs Inc (CLF) – 1,780,977 shares, 2.5% of the total portfolio. Shares reduced by 1.33%Finisar Corp (FNSR) – 349,639 shares, 1.39% of t

Top Heal Care Stocks To Buy Right Now: Endocyte, Inc.(ECYT)

Advisors’ Opinion:

  • [By Lisa Levin]

    Check out these big penny stock gainers and losers

    Losers
    Natural Health Trends Corp (NASDAQ: NHTC) fell 7.8 percent to $19.80 in pre-market trading after rising 1.46 percent on Friday.
    Endocyte, Inc. (NASDAQ: ECYT) shares fell 6.6 percent to $11.41 in pre-market trading after climbing 4.18 percent on Friday.
    Quorum Health Corporation (NYSE: QHC) shares fell 6.2 percent to $5.15 in pre-market trading after tumbling 11.45 percent on Friday.
    Arcadia Biosciences, Inc. (NASDAQ: RKDA) fell 6.1 percent to $7.31 in pre-market trading after declining 3.35 percent on Friday.
    Boston Scientific Corporation (NYSE: BSX) fell 5.6 percent to $28.30 in pre-market trading.
    Evofem Biosciences, Inc. (NASDAQ: EVFM) fell 5.3 percent to $6.06 in pre-market trading after gaining 2.73 percent on Friday.
    Xerox Corporation (NYSE: XRX) shares fell 5.2 percent to $28.60 in pre-market trading. Xerox terminated its transaction agreement with Fujifilm and entered into a new agreement with Carl Icahn and Darwin Deason. JP Morgan downgraded Xerox from Overweight to Neutral.
    Cellcom Israel Ltd. (NYSE: CEL) fell 5.2 percent to $7.02 in pre-market trading. Cellcom is expected to release Q1 results on May 30, 2018.
    Perrigo Company plc (NYSE: PRGO) fell 4.5 percent to $74 in pre-market trading.
    Nabriva Therapeutics plc (NASDAQ: NBRV) shares fell 4 percent to $4.66 in pre-market trading

  • [By Logan Wallace]

    Get a free copy of the Zacks research report on Endocyte (ECYT)

    For more information about research offerings from Zacks Investment Research, visit Zacks.com

  • [By ]

    Exploding biotech names are nothing new to this bull market. You might recall the headline swirling around Endocyte Inc. (NASDAQ:ECYT) as it posted one-day gains of more than 150% during the fourth quarter. The triple-digit move was sparked by a licensing agreement for the firms phase 3 prostate cancer drug. Now, these moves are becoming almost commonplace.

  • [By Joseph Griffin]

    Endocyte (NASDAQ:ECYT) is set to release its earnings data after the market closes on Monday, May 7th. Analysts expect Endocyte to post earnings of ($0.19) per share for the quarter.

  • [By Logan Wallace]

    Get a free copy of the Zacks research report on Endocyte (ECYT)

    For more information about research offerings from Zacks Investment Research, visit Zacks.com

Top Heal Care Stocks To Buy Right Now: AECOM(ACM)

Advisors’ Opinion:

  • [By Lisa Levin] Companies Reporting Before The Bell
    Dean Foods Company (NYSE: DF) is projected to report quarterly earnings at $0.11 per share on revenue of $1.85 billion.
    Discovery, Inc. (NASDAQ: DISCA) is expected to report quarterly earnings at $0.44 per share on revenue of $1.99 billion.
    Jacobs Engineering Group Inc. (NYSE: JEC) is estimated to report quarterly earnings at $0.89 per share on revenue of $3.63 billion.
    Henry Schein, Inc. (NASDAQ: HSIC) is expected to report quarterly earnings at $0.92 per share on revenue of $3.17 billion.
    Gartner, Inc. (NYSE: IT) is projected to report quarterly earnings at $0.57 per share on revenue of $926.18 million.
    The AES Corporation (NYSE: AES) is estimated to report quarterly earnings at $0.24 per share on revenue of $2.98 billion.
    Expeditors International of Washington, Inc. (NASDAQ: EXPD) is projected to report quarterly earnings at $0.64 per share on revenue of $1.71 billion.
    US Foods Holding Corp. (NYSE: USFD) is expected to report quarterly earnings at $0.32 per share on revenue of $5.98 billion.
    DISH Network Corporation (NASDAQ: DISH) is expected to report quarterly earnings at $0.7 per share on revenue of $3.50 billion.
    Zebra Technologies Corporation (NASDAQ: ZBRA) is estimated to report quarterly earnings at $2.06 per share on revenue of $936.98 million.
    Camping World Holdings, Inc. (NYSE: CWH) is expected to report quarterly earnings at $0.42 per share on revenue of $1.06 billion.
    Perrigo Company plc (NYSE: PRGO) is projected to report quarterly earnings at $1.14 per share on revenue of $1.21 billion.
    Petróleo Brasileiro S.A. – Petrobras (NYSE: PBR) is estimated to report quarterly earnings at $0.28 per share on revenue of $23.80 billion.
    JD.com, Inc. (NYSE: JD) is projected to report quarterly earnings at $0.18 per share on revenue of $15.65 billion.
    Valeant Pharmaceuticals International, Inc. (NYSE: VRX) is projected to report quarterly earnings at $0.6 per share o